rs150754122

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_033028.5(BBS4):​c.712-17C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0144 in 1,613,960 control chromosomes in the GnomAD database, including 201 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.010 ( 14 hom., cov: 29)
Exomes 𝑓: 0.015 ( 187 hom. )

Consequence

BBS4
NM_033028.5 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -1.50

Publications

0 publications found
Variant links:
Genes affected
BBS4 (HGNC:969): (Bardet-Biedl syndrome 4) This gene is a member of the Bardet-Biedl syndrome (BBS) gene family. Bardet-Biedl syndrome is an autosomal recessive disorder characterized by severe pigmentary retinopathy, obesity, polydactyly, renal malformation and cognitive disability. The proteins encoded by BBS gene family members are structurally diverse. The similar phenotypes exhibited by mutations in BBS gene family members are likely due to the protein's shared roles in cilia formation and function. Many BBS proteins localize to the basal bodies, ciliary axonemes, and pericentriolar regions of cells. BBS proteins may also be involved in intracellular trafficking via microtubule-related transport. The protein encoded by this gene has sequence similarity to O-linked N-acetylglucosamine (O-GlcNAc) transferases in plants and archaebacteria and in human forms a multi-protein "BBSome" complex with seven other BBS proteins. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Mar 2016]
BBS4 Gene-Disease associations (from GenCC):
  • Bardet-Biedl syndrome 4
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
  • ciliopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Bardet-Biedl syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 15-72731288-C-G is Benign according to our data. Variant chr15-72731288-C-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 262141.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0103 (1562/152130) while in subpopulation NFE AF = 0.0168 (1143/67974). AF 95% confidence interval is 0.016. There are 14 homozygotes in GnomAd4. There are 678 alleles in the male GnomAd4 subpopulation. Median coverage is 29. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 14 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BBS4NM_033028.5 linkc.712-17C>G intron_variant Intron 10 of 15 ENST00000268057.9 NP_149017.2 Q96RK4-1A0A0S2Z3A9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BBS4ENST00000268057.9 linkc.712-17C>G intron_variant Intron 10 of 15 1 NM_033028.5 ENSP00000268057.4 Q96RK4-1

Frequencies

GnomAD3 genomes
AF:
0.0103
AC:
1561
AN:
152012
Hom.:
14
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.00273
Gnomad AMI
AF:
0.0263
Gnomad AMR
AF:
0.00936
Gnomad ASJ
AF:
0.0121
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00291
Gnomad FIN
AF:
0.00473
Gnomad MID
AF:
0.00318
Gnomad NFE
AF:
0.0168
Gnomad OTH
AF:
0.0148
GnomAD2 exomes
AF:
0.00963
AC:
2422
AN:
251454
AF XY:
0.00937
show subpopulations
Gnomad AFR exome
AF:
0.00246
Gnomad AMR exome
AF:
0.00630
Gnomad ASJ exome
AF:
0.0143
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00411
Gnomad NFE exome
AF:
0.0158
Gnomad OTH exome
AF:
0.00831
GnomAD4 exome
AF:
0.0148
AC:
21610
AN:
1461830
Hom.:
187
Cov.:
31
AF XY:
0.0145
AC XY:
10512
AN XY:
727234
show subpopulations
African (AFR)
AF:
0.00224
AC:
75
AN:
33478
American (AMR)
AF:
0.00657
AC:
294
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0139
AC:
364
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00357
AC:
308
AN:
86246
European-Finnish (FIN)
AF:
0.00431
AC:
230
AN:
53412
Middle Eastern (MID)
AF:
0.00520
AC:
30
AN:
5764
European-Non Finnish (NFE)
AF:
0.0175
AC:
19457
AN:
1111976
Other (OTH)
AF:
0.0141
AC:
852
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
1201
2401
3602
4802
6003
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
720
1440
2160
2880
3600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0103
AC:
1562
AN:
152130
Hom.:
14
Cov.:
29
AF XY:
0.00912
AC XY:
678
AN XY:
74368
show subpopulations
African (AFR)
AF:
0.00272
AC:
113
AN:
41516
American (AMR)
AF:
0.00935
AC:
143
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0121
AC:
42
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.00291
AC:
14
AN:
4812
European-Finnish (FIN)
AF:
0.00473
AC:
50
AN:
10576
Middle Eastern (MID)
AF:
0.00685
AC:
2
AN:
292
European-Non Finnish (NFE)
AF:
0.0168
AC:
1143
AN:
67974
Other (OTH)
AF:
0.0147
AC:
31
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
74
148
221
295
369
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0138
Hom.:
1
Bravo
AF:
0.0105
Asia WGS
AF:
0.00173
AC:
6
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Bardet-Biedl syndrome 4 Benign:1
Oct 20, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Bardet-Biedl syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.0070
DANN
Benign
0.48
PhyloP100
-1.5
PromoterAI
0.0012
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs150754122; hg19: chr15-73023629; API